Login
From:
ALS News Today
(Uncensored)
subscribe
First SOD1-ALS patient dosed in trial of AMT-162 gene therapy
https://alsnewstoday.com/news/first-sod1-als-patient-dosed-trial-amt-162-gene-therapy/
links
backlinks
Tagged with:
sod1-als
first patient dosed
The first patient has been dosed in an open-label Phase 1/2 clinical trial of AMT-162, uniQure's one-time gene therapy for SOD1-ALS.
Roast topics
Find topics
Find it!
